According to Tilray 's latest financial reports and stock price the company's current Operating Margin is -31.56%. At the end of 2024 the company had an Operating Margin of -31.56%.
Year | Operating Margin | Change |
---|---|---|
2024 | -31.56% | -86.35% |
2023 | -231.24% | 229.74% |
2022 | -70.13% | 4.3% |
2021 | -67.24% | 149.61% |
2020 | -26.94% | 26.65% |
2019 | -21.27% | -121.9% |
2018 | 97.13% | 358.23% |
2017 | 21.20% | -322.89% |
2016 | -9.51% | -99.2% |
2015 | -1,186.63% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() Onconova Therapeutics ONTX | -8,391.15% | 26,487.93% | ๐บ๐ธ USA |
![]() OPKO Health
OPK | -0.08% | -99.75% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.